Region:Middle East
Author(s):Rebecca
Product Code:KRAD2354
Pages:87
Published On:January 2026

By Type:The market is segmented into various treatment types, including Surgical Treatment, Non-Surgical Treatment, Antibiotic Therapy, and Others. Surgical Treatment is gaining traction due to its effectiveness in severe cases of peri-implantitis through procedures such as open flap debridement and bone grafting, while Non-Surgical Treatment is preferred for its minimally invasive nature. Antibiotic Therapy is also significant, especially for patients with early-stage peri-implantitis. The Others category includes emerging therapies and adjunctive treatments.

By End-User:The end-user segmentation includes Dental Clinics, Hospitals, Research Institutions, and Others. Dental Clinics dominate the market due to their accessibility and specialized services in managing peri-implantitis. Hospitals also play a crucial role, particularly for complex cases requiring surgical intervention. Research Institutions contribute to the market through clinical studies and innovations in treatment methodologies.

The Oman Peri Implantitis Market is characterized by a dynamic mix of regional and international players. Leading participants such as Straumann Group, Dentsply Sirona, Nobel Biocare, Zimmer Biomet, BioHorizons, Osstem Implant, Bicon Dental Implants, Implant Direct, Megagen Implant, Hiossen Implant, Neodent, Alpha-Bio Tec, Southern Implants, Dentium, 3M Oral Care contribute to innovation, geographic expansion, and service delivery in this space.
The Oman peri-implantitis market is poised for significant growth, driven by increasing awareness of oral health and advancements in dental technology. As the population ages and the prevalence of dental implants rises, the demand for effective peri-implant disease management will intensify. Additionally, the integration of digital dentistry and minimally invasive techniques is expected to enhance treatment options, making them more accessible. Overall, the market is likely to evolve, focusing on preventive care and innovative solutions to address emerging challenges.
| Segment | Sub-Segments |
|---|---|
| By Type | Surgical Treatment Non-Surgical Treatment Antibiotic Therapy Others |
| By End-User | Dental Clinics Hospitals Research Institutions Others |
| By Patient Demographics | Age Group (Adults, Seniors) Gender (Male, Female) Socioeconomic Status (Low, Middle, High) Others |
| By Treatment Setting | In-Office Treatment Home Care Treatment Telehealth Consultations Others |
| By Geographic Distribution | Urban Areas Rural Areas Coastal Regions Others |
| By Treatment Duration | Short-term Treatment Long-term Treatment Maintenance Therapy Others |
| By Insurance Coverage | Insured Patients Uninsured Patients Government-funded Programs Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Dental Clinics Offering Implant Services | 60 | Dentists, Clinic Managers |
| Hospitals with Dental Departments | 40 | Oral Surgeons, Hospital Administrators |
| Dental Laboratories Providing Implant Solutions | 50 | Lab Technicians, Operations Managers |
| Dental Hygienists and Assistants | 50 | Dental Hygienists, Dental Assistants |
| Patients with Dental Implants | 50 | Implant Patients, Post-treatment Follow-up Participants |
The Oman Peri Implantitis Market is valued at approximately USD 42 million, reflecting a significant growth trend driven by the increasing prevalence of dental implants and heightened awareness of oral health among the population.